MedPath

A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients

Not Applicable
Completed
Conditions
Acute Decompensated Heart Failure
Interventions
Behavioral: Attention Control
Behavioral: multi-domain rehabilitation intervention
Registration Number
NCT02196038
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients, is a multicenter, randomized, attention-controlled, single-blind trial designed to examine the hypothesis that, in addition to standard care, a novel, tailored, progressive, multi-domain rehabilitation intervention administered to older patients with acute decompensated heart failure (ADHF) beginning early during hospitalization and continuing for 12 weeks will improve physical function and key clinical outcomes, including the rate of rehospitalization.

Detailed Description

There will be three lead centers, Wake Forest Baptist Health along with Thomas Jefferson University and Hospital-Co-Investigator Dr. David Whellan, and Duke University Medical Center-Co-Investigator Dr. Christopher O'Connor. Each center may recruit up to 3 geographically close, tightly affiliated 'satellite' sites under their management and budgetary control. Together, these sites will recruit a total of 352 consenting patients ≥ 60 years old hospitalized with ADHF. Following informed consent and baseline testing, the participants will be randomized in a 1:1 fashion to receive a 12-week novel, progressive, multi-domain rehabilitation and exercise training intervention or attention control. The multi-domain rehabilitation intervention will include endurance, mobility, strength, and balance training and will be tailored based on participant performance in each of these domains. It will begin upon randomization during the hospitalization and will continue 3 times per week in an outpatient setting. Participants randomized to the attention control arm will receive all services ordered by their primary physician and will be contacted bi-weekly by study staff. All participants will undergo measures of physical function and quality of life at baseline, 1 month, and 3 months. Clinical events will be monitored for 6 months following the index hospitalization.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
349
Inclusion Criteria
  • Age ≥ 60 years old
  • In the hospital setting >24 hours for the management of ADHF, or diagnosed with ADHF after being hospitalized for another reason. ADHF will be confirmed by the study physician, and will be defined according to the Food and Drug Administration definition of hospitalized heart failure as a combination of symptoms, signs, and HF-specific medical treatments.
Read More
Exclusion Criteria
  • Acute myocardial infarction
  • Planned discharge other than to home or a facility where the participant will live independently
  • Already actively participating in formal, facility-based cardiac rehabilitation
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Attention ControlAttention ControlUsual care group with bi-weekly contact from study staff
multi-domain rehabilitation interventionmulti-domain rehabilitation interventionIndividual, tailored, progressive, physical function rehabilitation intervention
Primary Outcome Measures
NameTimeMethod
Short Physical Performance Battery (SPPB) at Month 3Month 3

The Short Physical Performance Battery is scored on a scale of 0-12, with a higher score indicating better physical function.

Secondary Outcome Measures
NameTimeMethod
All-Cause RehospitalizationMonth 6

Number of all-cause rehospitalizations 6 months from index hospital discharge.

Trial Locations

Locations (3)

Wake Forest Baptist Health

🇺🇸

Winston-Salem, North Carolina, United States

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

Thomas Jefferson University and Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath